A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine
Patient-derived xenograft (PDX) models are increasingly being used in oncology drug development because they offer greater predictive value than traditional cell line models. Using novel tools to critique model validity and reliability we performed a systematic review to identify all original public...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
PeerJ Inc.
2018-11-01
|
| Sarja: | PeerJ |
| Aiheet: | |
| Linkit: | https://peerj.com/articles/5981.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|